4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-049813
See Remarks sold 200,650 shares at an average $100.51 ($20,167,954)
- See Remarks acquired 200,650 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lyon Joseph Douglas See Remarks | 2025-03-31 | Option exercise 10b5-1 | +35,000 | $13.56 | $474,600 | 44,009 | D |
| Lyon Joseph Douglas See Remarks | 2025-03-31 | Option exercise 10b5-1 | +75,000 | $16.52 | $1,239,000 | 119,009 | D |
| Lyon Joseph Douglas See Remarks | 2025-03-31 | Option exercise 10b5-1 | +40,000 | $15.82 | $632,800 | 159,009 | D |
| Lyon Joseph Douglas See Remarks | 2025-03-31 | Option exercise 10b5-1 | +50,000 | $19.26 | $963,000 | 209,009 | D |
| Lyon Joseph Douglas See Remarks | 2025-03-31 | Sale 10b5-1 | −162,008 | $100.22 | $16,236,571 | 47,001 | D |
| Lyon Joseph Douglas See Remarks | 2025-03-31 | Sale 10b5-1 | −32,942 | $101.37 | $3,339,416 | 14,059 | D |
| Lyon Joseph Douglas See Remarks | 2025-03-31 | Sale 10b5-1 | −5,050 | $102.48 | $517,523 | 9,009 | D |
| Lyon Joseph Douglas See Remarks | 2025-04-01 | Option exercise 10b5-1 | +650 | $13.56 | $8,814 | 9,659 | D |
| Lyon Joseph Douglas See Remarks | 2025-04-01 | Sale 10b5-1 | −650 | $114.53 | $74,443 | 9,009 | D |
| Derivatives | |||||||
| Lyon Joseph Douglas See Remarks | 2025-03-31 | Option exercise · Stock option (right to buy) 10b5-1 | −35,000 | 56,571 | D | ||
| Lyon Joseph Douglas See Remarks | 2025-03-31 | Option exercise · Stock option (right to buy) 10b5-1 | −75,000 | 0 | D | ||
| Lyon Joseph Douglas See Remarks | 2025-03-31 | Option exercise · Stock option (right to buy) 10b5-1 | −40,000 | 0 | D | ||
| Lyon Joseph Douglas See Remarks | 2025-03-31 | Option exercise · Stock option (right to buy) 10b5-1 | −50,000 | 50,000 | D | ||
| Lyon Joseph Douglas See Remarks | 2025-04-01 | Option exercise · Stock option (right to buy) 10b5-1 | −650 | 55,921 | D | ||
| Open-market sales · 200,650 sh · avg $100.51 · $20,167,954 | |||||||
Loading xslF345X05/ownership.xml…